These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 21179117

  • 1. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M, Healy BC, Glanz BI, Khoury SJ, Moscufo N, Weiner HL, De Jager PL, Guttmann CR.
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [Abstract] [Full Text] [Related]

  • 2. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Apr; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 3. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C, Pozzi-Mucelli R, Tommasi MA, Locatelli L, Ulivi S, Bratina A, Bosco A, Grop A, Cazzato G, Zorzon M.
    J Neurol; 2003 Sep; 250(9):1099-106. PubMed ID: 14504973
    [Abstract] [Full Text] [Related]

  • 4. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [Abstract] [Full Text] [Related]

  • 5. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.
    J Neurol Sci; 2007 Jul 15; 258(1-2):69-74. PubMed ID: 17412364
    [Abstract] [Full Text] [Related]

  • 6. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    Mult Scler; 2010 May 15; 16(5):526-32. PubMed ID: 20207784
    [Abstract] [Full Text] [Related]

  • 7. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ, Barnardo MC, Lui GZ, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Sadovnick AD, Ebers GC.
    Hum Mol Genet; 2007 Aug 15; 16(16):1951-8. PubMed ID: 17584771
    [Abstract] [Full Text] [Related]

  • 8. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL, Rodriguez-Rodero S, Tunon A, Martinez-Borra J, Vidal-Castineira JR, Lopez-Vazquez A, Rodrigo L, Rodrigo P, González S, Lahoz CH, Lopez-Larrea C.
    Tissue Antigens; 2008 Jul 15; 72(1):54-9. PubMed ID: 18588574
    [Abstract] [Full Text] [Related]

  • 9. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis.
    Sombekke MH, Lukas C, Crusius JB, Tejedor D, Killestein J, Arteta D, Martínez A, Uitdehaag BM, Knol DL, Peña AS, Geurts JJ, De Jager PL, Barkhof F, Vrenken H, Polman CH.
    Arch Neurol; 2009 Dec 15; 66(12):1531-6. PubMed ID: 20008659
    [Abstract] [Full Text] [Related]

  • 10. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM, Zhang KN, Wang CD, Xiong YQ, Liu Z, Qu XH, Xie XF.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2741-4. PubMed ID: 18167262
    [Abstract] [Full Text] [Related]

  • 11. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel.
    Benedek G, Paperna T, Avidan N, Lejbkowicz I, Oksenberg JR, Wang J, Brautbar C, Israel S, Miller A, Israeli MS Genetics group.
    Genes Immun; 2010 Jul 23; 11(5):423-31. PubMed ID: 20463743
    [Abstract] [Full Text] [Related]

  • 12. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG, Barreira AA, Louzada-Junior P, Mendes-Junior CT, Donadi EA.
    J Neuroimmunol; 2007 Sep 23; 189(1-2):118-24. PubMed ID: 17681614
    [Abstract] [Full Text] [Related]

  • 13. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M, Roshandel D, Omidnyia E, Rshaidbaghan A.
    Clin Immunol; 2011 Jun 23; 139(3):277-81. PubMed ID: 21396892
    [Abstract] [Full Text] [Related]

  • 14. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
    Aláez C, Corona T, Ruano L, Flores H, Loyola M, Gorodezky C.
    Acta Neurol Scand; 2005 Nov 23; 112(5):317-22. PubMed ID: 16218914
    [Abstract] [Full Text] [Related]

  • 15. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O, Fernández V, Alonso A, Caballero A, Luque G, Bravo M, León A, Mayorga C, Leyva L, de Ramón E.
    J Neurol; 2004 Apr 23; 251(4):440-4. PubMed ID: 15083289
    [Abstract] [Full Text] [Related]

  • 16. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):123-30. PubMed ID: 19232441
    [Abstract] [Full Text] [Related]

  • 17. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
    Handel AE, De Luca GC, Morahan J, Handunnetthi L, Sadovnick AD, Ebers GC, Ramagopalan SV.
    J Neuroimmunol; 2010 Jun 30; 223(1-2):120-3. PubMed ID: 20394989
    [Abstract] [Full Text] [Related]

  • 18. HLA class II alleles and multiple sclerosis in Tunisian patients.
    Messadi A, Najiba FM, Ouerhani S, Zaweli J, Louatti I, Layouni S, Nciri B, Bouaicha G, Kouki W, Yedeas M, Raies A, Mrissa R, Gritli N.
    Clin Neurol Neurosurg; 2010 Dec 30; 112(10):849-52. PubMed ID: 20691532
    [Abstract] [Full Text] [Related]

  • 19. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    J Neurol Sci; 2010 Jan 15; 288(1-2):63-7. PubMed ID: 19879597
    [Abstract] [Full Text] [Related]

  • 20. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C, Guerini FR, Rombolà G, Rosati E, Massacesi L, Ferrante P, Caputo D, Talamanca LF, Naldi P, Liguori M, Alizadeh M, Momigliano-Richiardi P, D'Alfonso S.
    J Neuroimmunol; 2004 May 15; 150(1-2):178-85. PubMed ID: 15081263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.